Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
MORE >>
Recently, Tanzania’s first IVD (in vitro diagnostics) reagent factory which combining Genrui’s technology with German capital has officially put into operation. A grand opening ceremony was held, an...
MORE >>
The Novel Coroanvirus (2019-nCoV) Nucleic Acid Detection Kit (RT-PCR) has acquired CE mark. The declaration of conformity can be provided upon request.
MORE >>
Shenzhen, China, Nov. 11, 2020 -Genrui Biotech Inc., a Shenzhen- based leading Chinese company specialized in developing, manufacturing and marketing IVD equipment and reagents announced a new brand- Genvet, and a series of professional veterinary diagnosis equipment.
MORE >>
According to the latest news, Singapore has already made the registration of its local medical regulation authority, and it can be checked on the IMDRF list.
MORE >>
The study, conducted by The Health Service of The Balearic Islands (https://www.ibsalut.es/) in Spain, has concluded that COVID-19 IgM/IgG antibody rapid test is important for the fight against COVID-19 and that Genrui's Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit (Colloidal Gold) is particularly recommended.
MORE >>
Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit (Colloidal gold) is now available in stock!COVID-19 is a disease caused by novel coronavirus.
MORE >>
We're excited to announce that we have moved our headquarters into a brand new office building (address: 4-10F, Building 3, Geya Technology Park, Guangming District, 518106, Shenzhen, P.R.China).
MORE >>